TipRanks
Cardiol Therapeutics (DE:CT9)
FRANKFURT:CT9
Germany Market
CT9
Cardiol Therapeutics
RESEARCH TOOLSreports

Cardiol Therapeutics (CT9) Cash flow

0 Followers

Cardiol Therapeutics Cash Flow

DE:CT9's free cash flow for Q2 2026 was C$-4.38M. For the 2026 fiscal year, DE:CT9's free cash flow was decreased by C$1.20M and operating cash flow was C$-4.38M. See a summary of the company’s cash flow.
Cash Flow
Mar 26Mar 25Mar 24Dec 22Dec 21
Operating Cash Flow
C$ -23.85MC$ -25.06MC$ -25.18KC$ -27.22MC$ -23.55M
Investing Cash Flow
C$ -24.48KC$ -21.29KC$ -64.31KC$ -74.71KC$ -12.92K
Financing Cash Flow
C$ 15.54MC$ 18.84MC$ -55.38KC$ -53.93KC$ 93.44M
End Cash Position
C$ 21.42MC$ 30.58MC$ 34.93KC$ 59.47MC$ 83.90M
Free Cash Flow
C$ -23.88MC$ -25.08MC$ -25.25KC$ -27.30MC$ -23.56M
Currency in CAD

Cardiol Therapeutics Cash Flow